Effect of silver on burn wound infection control and healing: review of the literature.

Silver compounds have been exploited for their medicinal properties for centuries. At present, silver is reemerging as a viable treatment option for infections encountered in burns, open wounds, and chronic ulcers. The gold standard in topical burn treatment is silver sulfadiazine (Ag-SD), a useful antibacterial agent for burn wound treatment. Recent findings, however, indicate that the compound delays the wound-healing process and that silver may have serious cytotoxic activity on various host cells. The present review aims at examining all available evidence about effects, often contradictory, of silver on wound infection control and on wound healing trying to determine the practical therapeutic balance between antimicrobial activity and cellular toxicity. The ultimate goal remains the choice of a product with a superior profile of infection control over host cell cytotoxicity.

[1]  A. W. Wilkinson,et al.  RESEARCH IN BURNS , 1968 .

[2]  A. Bard,et al.  Chemical, Electrochemical, Gravimetric, and Microscopic Studies on Antimicrobial Silver Films , 2002 .

[3]  C. Lok,et al.  [Topical silver sulfadiazine-induced acute renal failure]. , 2005, Annales de dermatologie et de venereologie.

[4]  R. Burrell,et al.  Infection and the chronic wound: a focus on silver. , 2005, Advances in skin & wound care.

[5]  C. Rowland‐Payne Argyria from excessive use of topical silver sulphadiazine , 1992 .

[6]  R. Zapata-Sirvent,et al.  Tissue deposition of silver following topical use of silver sulphadiazine in extensive burns. , 1985, Burns, including thermal injury.

[7]  L. Salas Campos,et al.  [Topical chemotherapy for the treatment of burns]. , 2005, Revista de enfermeria.

[8]  D. Smith,et al.  Regional and institutional variation in burn care. , 1995, Journal of Burn Care and Rehabilitation.

[9]  R. F. Ryan Topical therapy of burns. , 1972, Postgraduate medicine.

[10]  P. Friden,et al.  Antimicrobial activity of silver nitrate against periodontal pathogens. , 2001, Journal of periodontal research.

[11]  R. Burrell,et al.  Efficacy of topical silver against fungal burn wound pathogens. , 1999, American journal of infection control.

[12]  Ş. Çavuşlu,et al.  Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and silver sulfadiazine 1% (Silverdin) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats. , 2005, The Journal of burn care & rehabilitation.

[13]  D. Mitlin,et al.  Impact of heat on nanocrystalline silver dressings. Part II: Physical properties. , 2005, Biomaterials.

[14]  S. Bohbot,et al.  A silver sulphadiazine-impregnated lipidocolloid wound dressing to treat second-degree burns. , 2004, Journal of wound care.

[15]  V. Poon,et al.  Antimicrobial activities of silver dressings: an in vitro comparison. , 2006, Journal of medical microbiology.

[16]  J. Fish,et al.  The use of silver coated dressings on donor site wounds: a prospective, controlled matched pair study. , 2001, Burns : journal of the International Society for Burn Injuries.

[17]  G. Turnbull A look at the purpose and outcomes of colostomy irrigation. , 2003, Ostomy/wound management.

[18]  R. Kimble,et al.  Cytotoxicity of topical antimicrobial agents used in burn wounds in Australasia , 2004, ANZ journal of surgery.

[19]  C. Bladin,et al.  Argyria from excessive use of topical silver sulphadiazine , 1992, The Lancet.

[20]  C. Mkony,et al.  A comparison of topical Phenytoin with Silverex in the treatment of superficial dermal burn wounds. , 2002, The Central African journal of medicine.

[21]  M. Trop Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. , 2006, The Journal of trauma.

[22]  A. Buret,et al.  Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing , 2002, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[23]  Michael Wagener,et al.  An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. , 2004, Biomaterials.

[24]  P. Lam,et al.  In vitro cytotoxicity testing of a nanocrystalline silver dressing (Acticoat) on cultured keratinocytes. , 2004, British journal of biomedical science.

[25]  R. Burrell,et al.  Impact of heat on nanocrystalline silver dressings. Part I: Chemical and biological properties. , 2005, Biomaterials.

[26]  A. Mason,et al.  Topical silver treatment after escharectomy of infected full thickness burn wounds in rats. , 2005, The Journal of trauma.

[27]  A. Lansdown,et al.  Silver. 2: Toxicity in mammals and how its products aid wound repair. , 2002, Journal of wound care.

[28]  W. Eaglstein,et al.  Wound healing. The effects of topical antimicrobial agents. , 1979, Archives of dermatology.

[29]  K. Bader Organ Deposition of Silver Following Silver Nitrate Therapy of Burns , 1966, Plastic and reconstructive surgery.

[30]  G. Young,et al.  Myoclonic status epilepticus following repeated oral ingestion of colloidal silver , 2004, Neurology.

[31]  R. Conyers,et al.  Determination of silver in blood, urine, and tissues of volunteers and burn patients. , 1991, Clinical chemistry.

[32]  E. Capodaglio,et al.  Effects of silver in isolated rat hepatocytes. , 1988, Toxicology letters.

[33]  H. N. Harrison Pharmacology of sulfadiazine silver. Its attachment to burned human and rat skin and studies of gastrointestinal absorption and extension. , 1979, Archives of surgery.

[34]  J. Lawrence,et al.  Mechanism of Prophylaxis by Silver Compounds against Infection of Burns , 1970, British medical journal.

[35]  H. Klasen,et al.  A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. , 2000, Burns : journal of the International Society for Burn Injuries.

[36]  A. Hendry,et al.  Silver-resistant Enterobacteriaceae from hospital patients. , 1979, Canadian journal of microbiology.

[37]  C. Rix,et al.  Passage of silver ions through membrane-mimetic materials, and its relevance to treatment of burn wounds with silver sulfadiazine cream. , 1997, Clinical chemistry.

[38]  R. Burrell,et al.  Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment. , 1998, American journal of infection control.

[39]  R. Robinson,et al.  Benign Rheumatoid Arthritis of the Aged , 1974, British medical journal.

[40]  R. Demling,et al.  The rate of re-epithelialization across meshed skin grafts is increased with exposure to silver. , 2002, Burns : journal of the International Society for Burn Injuries.

[41]  D. Herndon,et al.  In vitro toxicity of topical antimicrobial agents to human fibroblasts. , 1989, The Journal of surgical research.

[42]  R. Kirsner,et al.  MATRIX METALLOPROTEINASES IN NORMAL AND IMPAIRED WOUND HEALING: A POTENTIAL ROLE OF NANOCRYSTALLINE SILVER , 2001 .

[43]  J. Heggers,et al.  Acticoat versus Silverlon: The Truth , 2002 .

[44]  R. Conyers,et al.  Do burn patients have a silver lining? , 1992, Burns : journal of the International Society for Burn Injuries.

[45]  H. Westh,et al.  Bacterial colonization and healing of venous leg ulcers , 1996, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[46]  A. Massè,et al.  Silver coated materials for external fixation devices: in vitro biocompatibility and genotoxicity. , 2002, Biomaterials.

[47]  Y. Akagawa,et al.  Cytotoxicity of antimicrobial tissue conditioners containing silver-zeolite. , 2003, The International journal of prosthodontics.

[48]  R. E. Hall,et al.  Inhibitory and cidal antimicrobial actions of electrically generated silver ions. , 1987, Journal of oral and maxillofacial surgery.

[49]  M. Robson Wound Infection: A Failure of Wound Healing Caused by an Imbalance of Bacteria , 1997 .

[50]  M. Hollinger Toxicological aspects of topical silver pharmaceuticals. , 1996, Critical reviews in toxicology.

[51]  J. Gearhart,et al.  In vitro toxicity of nanoparticles in BRL 3A rat liver cells. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.

[52]  Y. Kuroyanagi,et al.  Evaluation of a synthetic wound dressing capable of releasing silver sulfadiazine. , 1991, The Journal of burn care & rehabilitation.

[53]  Dickinson Sj Topical therapy of burns in children with silver sulfadiazine. , 1973 .

[54]  C. McClain,et al.  Serum and urinary silver levels in thermal injury patients. , 1987, Surgery.

[55]  K. Dunn,et al.  The role of Acticoat with nanocrystalline silver in the management of burns. , 2004, Burns : journal of the International Society for Burn Injuries.

[56]  H. Stern Silver sulphadiazine and the healing of partial thickness burns: a prospective clinical trial. , 1989, British journal of plastic surgery.

[57]  J. Schlager,et al.  In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[58]  William J. Chancellor,et al.  Soil Physical Properties , 1994 .

[59]  J. Hamilton-miller,et al.  Comparison of the in-vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus. , 1992, The Journal of antimicrobial chemotherapy.

[60]  Ae-Ri Cho Lee,et al.  Reversal of silver sulfadiazine-impaired wound healing by epidermal growth factor. , 2005, Biomaterials.

[61]  W. Stanford,et al.  Clinical experience with silver sulfadiazine, a new topical agent for control of pseudomonas infections in burns. , 1969, The Journal of trauma.

[62]  R. Burrell,et al.  An Electrochemical Analysis of Thin Silver Films Produced by Reactive Sputtering , 2001 .

[63]  R. Burrell,et al.  Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. , 1999, The Journal of burn care & rehabilitation.

[64]  A D Russell,et al.  Antimicrobial activity and action of silver. , 1994, Progress in medicinal chemistry.

[65]  D. Supp,et al.  Evaluation of cytotoxicity and antimicrobial activity of Acticoat Burn Dressing for management of microbial contamination in cultured skin substitutes grafted to athymic mice. , 2005, The Journal of burn care & rehabilitation.

[66]  A. Griffiths-Jones Methicillin-resistant Staphylococcus aureus in wound care. , 1995, Journal of wound care.

[67]  S. Shah,et al.  Silver sulphadiazine: a comprehensive in vitro reassessment. , 1993, Chemotherapy.

[68]  Martínez de la Chica Am,et al.  Topical chemotherapy for the treatment of burns , 2005 .

[69]  A. Lansdown,et al.  Silver. I: Its antibacterial properties and mechanism of action. , 2002, Journal of wound care.

[70]  F. Vazquez,et al.  Resistance to antibiotics and inorganic ions in virulent bacterial strains from a hospital. , 1989, Journal of chemotherapy.

[71]  S. Modak,et al.  Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa. , 1973, Biochemical pharmacology.

[72]  K. Neoh,et al.  In vitro antibacterial and cytotoxicity assay of multilayered polyelectrolyte-functionalized stainless steel. , 2006, Journal of biomedical materials research. Part A.

[73]  Fu-qiang Zhang,et al.  [Comparison of the cytotoxicity in vitro among six types of nano-silver base inorganic antibacterial agents]. , 2005, Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology.

[74]  D. Bassett,et al.  A study of 245 infected surgical wounds in Singapore. , 1992, The Journal of hospital infection.

[75]  H J Klasen,et al.  Historical review of the use of silver in the treatment of burns. I. Early uses. , 2000, Burns : journal of the International Society for Burn Injuries.

[76]  R. Sheridan,et al.  Once-daily wound cleansing and dressing change: efficacy and cost. , 1997, The Journal of burn care & rehabilitation.

[77]  C. Lok,et al.  Insuffisance rénale aiguë après application topique de sulfadiazine argentique , 2005 .

[78]  M. Robson,et al.  Wound Infection: A Failure of Wound Healing Caused by an Imbalance of Bacteria , 1997 .

[79]  C. Sawhney,et al.  Long-term experience with 1 per cent topical silver sulphadiazine cream in the management of burn wounds. , 1989, Burns : journal of the International Society for Burn Injuries.

[80]  C. Moyer,et al.  Treatment of Large Human Burns With 0.5% Silver Nitrate Solution , 1965 .

[81]  H. Nikaido,et al.  Silver-resistant mutants of Escherichia coli display active efflux of Ag+ and are deficient in porins , 1997, Journal of bacteriology.

[82]  S. Chhibber,et al.  Susceptibility of multidrug-resistant isolates ofKlebsiella pneumoniae to silver nitrate , 2008, Folia Microbiologica.

[83]  J. Laws State-of-the-art burn treatment. , 1996, Occupational health & safety.

[84]  S. Sano,et al.  Absorption, excretion and tissue distribution of silver sulphadiazine. , 1982, Burns, including thermal injury.

[85]  H. Liedberg,et al.  Assessment of silver-coated urinary catheter toxicity by cell culture , 2004, Urological Research.

[86]  A. Gupta,et al.  Effects of Halides on Plasmid-Mediated Silver Resistance in Escherichia coli , 1998, Applied and Environmental Microbiology.

[87]  R. Burrell A scientific perspective on the use of topical silver preparations. , 2003, Ostomy/Wound Management.

[88]  V. Poon,et al.  In vitro cytotoxity of silver: implication for clinical wound care. , 2004, Burns : journal of the International Society for Burn Injuries.

[89]  K. Ziegler,et al.  Reduced Cellular Toxicity of a New Silver-Containing Antimicrobial Dressing and Clinical Performance in Non-Healing Wounds , 2006, Skin Pharmacology and Physiology.